DARPP-32:调节多巴胺基神经传递的疗效
A A Fienberg1, N Hiroi, P G Mermelstein
1Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY 10021, USA.
概括
DARPP-32对于大脑中多巴胺信号传递至关重要. 缺乏这种蛋白质的小鼠在对多巴胺的反应中表现出显著的缺陷,这表明它在调节多巴胺神经递质中起着核心作用.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 多巴氨基神经元调节前脑活动.
- DARPP-32在接受多巴胺基输入的神经元中发现.
- 多巴胺将DARPP-32转化为蛋白质酸酶抑制剂.
研究的目的:
- 调查DARPP-32在多巴胺基神经传递中的作用.
- 了解DARPP-32缺乏对神经反应的影响.
主要方法:
- 基因向可以创建DARPP-32淘汰小鼠.
- 评估分子,电生理学和行为反应.
主要成果:
- DARPP-32淘汰赛小鼠表现出严重的缺陷.
- 这些缺陷在对多巴胺,滥用药物和抗精神病药物的反应中观察到.
- 这项研究强调了DARPP-32.2.的关键功能.
结论:
- DARPP-32对于多巴胺基神经传递的有效性至关重要.
- 它在调解对多巴胺和相关药物的反应方面发挥着核心作用.
相关概念视频
Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...


